Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease

RT @JamesLomas88: See our new research in PharmacoEconomics Open: Which Costs Matter? Costs Included in Economic Evaluation and their Impa…

RT @JamesLomas88: See our new research in PharmacoEconomics Open: Which Costs Matter? Costs Included in Economic Evaluation and their Impa…

@JamesLomas88 published @CLAHRCYH #HEOM Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease https://t.co/6ZZ8px8CiF

#Which Costs Matter# https://t.co/rrZhOKR1Ac

RT @miqedup: Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty - latest paper with @JamesL…

RT @JamesLomas88: See our new research in PharmacoEconomics Open: Which Costs Matter? Costs Included in Economic Evaluation and their Impa…

RT @JamesLomas88: See our new research in PharmacoEconomics Open: Which Costs Matter? Costs Included in Economic Evaluation and their Impa…

RT @miqedup: Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty - latest paper with @JamesL…

RT @miqedup: Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty - latest paper with @JamesL…

Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty - latest paper with @JamesLomas88 @bojke_laura @cpgale3 and others @CHEyork https://t.co/zwoXAqT7x4 #healtheconomics

RT @JamesLomas88: See our new research in PharmacoEconomics Open: Which Costs Matter? Costs Included in Economic Evaluation and their Impa…

RT @JamesLomas88: See our new research in PharmacoEconomics Open: Which Costs Matter? Costs Included in Economic Evaluation and their Impa…

RT @JamesLomas88: See our new research in PharmacoEconomics Open: Which Costs Matter? Costs Included in Economic Evaluation and their Impa…

RT @JamesLomas88: See our new research in PharmacoEconomics Open: Which Costs Matter? Costs Included in Economic Evaluation and their Impa…

RT @cpgale3: Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery…

RT @cpgale3: Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery…

RT @cpgale3: Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery…

Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease ...worth a peep... https://t.co/KNo636QXlG

RT @JamesLomas88: See our new research in PharmacoEconomics Open: Which Costs Matter? Costs Included in Economic Evaluation and their Impa…

@CLAHRCYH #HEOM https://t.co/5GJMY4FRHu

See our new research in PharmacoEconomics Open: Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease https://t.co/T4qORiCqcv

RT @HealthEconBot: #HealthEconJA Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Sta…

RT @HealthEconBot: #HealthEconJA Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Sta…

#HealthEconJA Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease https://t.co/8JLGl7Mfbh